Animals Rule: SIGA’s Smallpox Drug Tecovirimat Sails Through US FDA Panel

Antiviral wins unanimous endorsement on strength of efficacy data in two animal models and absence of major safety concerns in humans. FDA's advisors also see potential utility in other orthopoxviruses, particularly naturally occurring monkeypox outbreaks in Africa.